AstraZeneca, the British-Swedish multinational pharmaceutical company currently collaborating with the University of Oxford on a COVID-19 vaccine, will purchase Alexion Pharmaceuticals for $39 billion. The transaction, which awaits approval by shareholders and regulators, is the largest purchase by a health
One of the first things entrepreneurs will need to do when branding new companies is to seek and obtain trademark protection. In addition, companies may at times seek to use third party trademarks without formally licensing those trademarks. These situations
Founders of technology-based companies often recognize very early on that their company’s IP and related technology comprise a significant or even central part of the company’s overall value. Determining how to best protect and leverage that IP and tech to
Centripetal Networks, Inc. (“Centripetal”), one of the fastest growing innovators in the cybersecurity space, leveraged its patent portfolio against Cisco Systems, Inc. (“Cisco”) and was recently awarded an estimated $2-3 billion in damages by the Eastern District of Virginia following
Quick heads up, the World Economic Forum released a Special Report covering what it considers to the the top 10 emerging technologies of 2020 that “have the greatest potential to positively transform society and industry. The technologies listed include:
As Pfizer and BioNTech announced this week that results of their COVID-19 vaccine have exceeded expectations, the technology behind the vaccine (messenger RNA, or mRNA) has taken center stage. Last month, Moderna Therapeutics, one of the other global leaders in
In the fast-paced and dynamic environment of startup and emerging companies, standard operating procedures and compliance matters may often fall by the wayside. However, it is important for management and employees to understand their obligations for retaining documents, particularly electronic
At this point we have all heard how artificial intelligence (AI) will change the world, and many of us have already integrated AI-based products and services into our lives—from voice recognition devices in our homes to predictive and safety features
On October 22, 2020, Boston-based Atea Pharmaceuticals, Inc. (“Atea”) announced an agreement with Roche for the exclusive rights to research, develop and distribute AT-527 as an oral antiviral treatment for COVID-19 in territories outside of the United States. Under the
